Kolexia
Stein Ulrich Oncologie médicale
Stein Ulrich
Oncologie médicale
Hôpital Jean-Minjoz
Besançon, France
56 Activités
139 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Tumeurs de la prostate Tumeurs du rein Tumeurs du sein Métastase tumorale

Collaborateurs

Voir plus
Thiery-Vuillemin Antoine
Thiery-Vuillemin Antoine
Le Mittan Annexe Du Hnfc, Montbéliard, France
Maurina Tristan
Maurina Tristan
Hôpital Nord Franche-Comté, Montbéliard, France
Mouillet Guillaume
Mouillet Guillaume
Hôpital Jean-Minjoz, Besançon, France
Almotlak Hamadi
Almotlak Hamadi
Centre Hospitalier de Lons, Lons-le-Saunier, France

Industries

Voir plus
A+A
6 collaboration(s)
Dernière en 2023
Ipsen
5 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2023
All Global
4 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
The role of menin inhibitors in the treatment of HR-MDS and AML
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   01 juin 2023
Preclinical safety and efficacy of CD123-NK cell engager in R/R AML
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   01 juin 2023
Differences and similarities between MDS and AML & how this can inform treatment decisions
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   10 mai 2023
A Phase II trial evaluating E7820 in patients with AML with splicing factor mutations
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   01 avril 2023
The safety and efficacy of revumenib in patients with KMT2A-rearranged or NPM1-mutated AML
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   01 avril 2023
Evaluation of drug-drug interactions among patients with metastatic prostate cancer in routine care.
2022 ASCO Genitourinary Cancers Symposium   16 février 2022
Real-word evidence in patients treated with pazopanib for advanced/metastatic renal cell carcinoma (mRCC): The APOLON study.
2022 ASCO Genitourinary Cancers Symposium   16 février 2022
SURF: Open Label, Randomised Multi-centre Phase II Study to Assess the Efficacy and Tolerability of Sunitinib by Dose Administration Regimen (Dose Modification or Dose Interruptions) in Patients With Advanced or Metastatic Renal Cell Carcinoma
Essai Clinique (Pfizer)   17 novembre 2021
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.
European journal of cancer (Oxford, England : 1990)   26 mars 2021
Association of health-related quality of life (HRQOL) variations with biological biomarkers for patients with metastatic castrate-resistant prostate cancer (MCRPC) treated by abiraterone/prednisone combination or prednisone.
2021 Genitourinary Cancers Symposium   02 mars 2021